Abera Bioscience AB
Developing next-generation nasal vaccines using modular OMV platform technology.
Översikt
- Okänt
- Anställda
- Okänt
- Omsättning
- 2012
- Grundat
Nyckelbeslutsfattare
Maria Alriksson
CEO
Mats Lundgren
CSO
Anders Ericsson
Executive Chairman of the Board
Joen Luirink
CTO, Co-Founder
+3 fler kontakter i Funnelfeedr
Beskrivning
Abera Bioscience AB is a Swedish biotechnology company specializing in the development of next-generation vaccines. They utilize a proprietary, modular Outer Membrane Vesicle (OMV) platform technology. This platform allows for rapid design and cost-effective production of vaccines that induce robust...